OXT and Ehlers-Danlos syndrome: Forty‐eight female adolescents aged 16 to 17 years with and without EDs took part in a placebo‐controlled, double‐blinded, randomised, crossover trial investigating the effects of 24 IU intranasal oxytocin on negative interpretations of ambiguous scenarios.